Pharmaceutical industry bristles under FDA draft guidance

The amount of FDA draft guidance in play during the past few months has drawn skepticism from the pharmaceutical industry, which has its own thoughts on how best to address the broad scope of the agency’s proposed authority. Jaclyn Jaeger reports.